TMC Life Sciences Bhd (XKLS:0101) Cash-to-Debt : 0.89 (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is TMC Life Sciences Bhd Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. TMC Life Sciences Bhd's cash to debt ratio for the quarter that ended in Dec. 2023 was 0.89.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, TMC Life Sciences Bhd couldn't pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for TMC Life Sciences Bhd's Cash-to-Debt or its related term are showing as below:

XKLS:0101' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.64 Med: 22.42 Max: 122.03
Current: 0.89

During the past 13 years, TMC Life Sciences Bhd's highest Cash to Debt Ratio was 122.03. The lowest was 0.64. And the median was 22.42.

XKLS:0101's Cash-to-Debt is ranked better than
55.42% of 664 companies
in the Healthcare Providers & Services industry
Industry Median: 0.68 vs XKLS:0101: 0.89

TMC Life Sciences Bhd Cash-to-Debt Historical Data

The historical data trend for TMC Life Sciences Bhd's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

TMC Life Sciences Bhd Cash-to-Debt Chart

TMC Life Sciences Bhd Annual Data

Trend

May13

May14

May15

May16

Aug17

Aug18

Aug19

Jun21

Jun22

Jun23

Cash-to-Debt

Get a 7-Day Free Trial

117.78

109.95

0.79

0.66

0.74

TMC Life Sciences Bhd Quarterly Data
	Nov18	Feb19	May19	Aug19	Nov19	Feb20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial															0.64	0.68	0.74	0.84	0.89

Competitive Comparison of TMC Life Sciences Bhd's Cash-to-Debt

For the Medical Care Facilities subindustry, TMC Life Sciences Bhd's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TMC Life Sciences Bhd's Cash-to-Debt Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, TMC Life Sciences Bhd's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where TMC Life Sciences Bhd's Cash-to-Debt falls into.

TMC Life Sciences Bhd Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

TMC Life Sciences Bhd's Cash to Debt Ratio for the fiscal year that ended in Jun. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	162.38	/	(17.691	+	201.368)
	=	0.74

TMC Life Sciences Bhd's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	190.337	/	(17.685	+	195.857)
	=	0.89

TMC Life Sciences Bhd (XKLS:0101) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

TMC Life Sciences Bhd Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of TMC Life Sciences Bhd's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

TMC Life Sciences Bhd (XKLS:0101) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » TMC Life Sciences Bhd (XKLS:0101) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 11, PJU 5, Jalan Teknologi, Level 11, Taman Sains, Kota Damansara, Petaling Jaya, SGR, MYS, 47810

Website

https://www.tmclife.com

TMC Life Sciences Bhd is an investment holding company operating a multi-disciplinary tertiary care center and fertility center in Malaysia. It operates Tropicana Medical Centre, Kota Damansara (TMCKD), a medical center located in Petaling Jaya. Its TMCKD provides healthcare services in various medical/surgical specialties and subspecialties, including anesthesiology, cancer, cardiology, colorectal, dermatology, ENT, fertility, gastroenterology, as well as offers internal medicines and respiratory medicines. Its fertility center provides a range of fertility treatments for couples. The company also operates a women's clinic; provides fertility consultancy, laboratory, and embryology services; and offers pharmacy services and products.

TMC Life Sciences Bhd (XKLS:0101) Headlines

No Headlines